Fertility Preservation in Young Women With Cancer

NCT02878434 · tracked via the Priya Life Science Netherlands tracker

Sponsor

University Hospital, Gasthuisberg

Phase

Observational

Started

2017-05-23

Last updated

2020-11-18

Condition(s) studied

CancerFertility

Study summary

The researchers aim to record the incidence, treatment and long term follow up of fertility preserving cancer treatment. Both the oncological and fertility outcome are recorded.

Study population: All patients with a cancer for whom a fertility preserving cancer treatment is applied. The results of the study population are compared to young women undergoing standard cancer treatment.

Eligibility

Sex

FEMALE

Min age

0 Years

Max age

40 Years

Healthy volunteers

Inclusion Criteria: * Young women who want to preserve their fertility during cancer treatment. Patients need to give their signed and written informed consent to participate in the study. Exclusion Criteria: * Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent

Primary outcome measure(s)

Fertility Outcome — 10 years
pregnancy rate

Trial sites (2)

Facility	City	Region	Status
UZ Gasthuisberg, Katholieke Universiteit Leuven	Leuven	Belgium	Recruiting
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital	Amsterdam	Netherlands	Recruiting

More University Hospital, Gasthuisberg trials in the Netherlands

Effects of Oncological Treatment During Pregnancy on Mother and Child Recruiting

Other trials for the same condition

Pan Tumor Rollover Study Recruiting

Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience Recruiting

The Drug Rediscovery Protocol (DRUP Trial) Recruiting

Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention) Recruiting

Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02878434 on ClinicalTrials.gov ↗ ← All trials in the Netherlands